Key Financial Data Of Reporting Company

Carna Biosciences, Inc. - Filing #7613644

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
As at
2018-12-31
As at
2018-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
2017-01-01 to
2017-12-31
2017-01-01 to
2017-12-31
As at
2017-12-31
As at
2017-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
1,931,718,000 JPY
2,017,529,000 JPY
1,133,346,000 JPY
1,042,960,000 JPY
3,207,423,000 JPY
3,070,843,000 JPY
754,691,000 JPY
640,711,000 JPY
560,426,000 JPY
657,516,000 JPY
Ordinary profit (loss)
-548,843,000 JPY
-522,992,000 JPY
-1,077,096,000 JPY
-1,096,348,000 JPY
957,161,000 JPY
874,478,000 JPY
-1,159,223,000 JPY
-1,156,637,000 JPY
-703,602,000 JPY
-711,496,000 JPY
Profit (loss)
-556,425,000 JPY
-1,129,612,000 JPY
745,709,000 JPY
-1,199,225,000 JPY
-762,897,000 JPY
Share capital
1,056,953,000 JPY
558,829,000 JPY
4,657,466,000 JPY
3,591,568,000 JPY
3,226,487,000 JPY
Total number of issued shares
13,313,400 xbrli:shares
12,407,100 xbrli:shares
11,654,500 xbrli:shares
10,139,600 xbrli:shares
9,551,300 xbrli:shares
Net assets
4,194,643,000 JPY
4,315,572,000 JPY
3,741,428,000 JPY
3,824,010,000 JPY
3,853,522,000 JPY
3,781,463,000 JPY
900,044,000 JPY
887,453,000 JPY
1,377,908,000 JPY
1,377,716,000 JPY
Total assets
5,305,486,000 JPY
5,432,560,000 JPY
4,748,867,000 JPY
4,835,356,000 JPY
5,376,610,000 JPY
5,302,570,000 JPY
1,780,565,000 JPY
1,770,090,000 JPY
2,190,386,000 JPY
2,185,030,000 JPY
Net assets per share
314.45
323.54
301.39
308.05
329.86
323.68
88.07
86.83
142.68
142.66
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-43.83
-42.10
-90.33
-91.84
76.05
68.47
-125.02
-123.85
-81.26
-78.53
Diluted earnings per share
74.51
67.08
Equity-to-asset ratio
0.789 xbrli:pure
0.793 xbrli:pure
0.787 xbrli:pure
0.790 xbrli:pure
0.715 xbrli:pure
0.711 xbrli:pure
0.501 xbrli:pure
0.497 xbrli:pure
0.622 xbrli:pure
0.624 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
0.351 xbrli:pure
0.320 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
27.9 xbrli:pure
31.0 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,536,612,000 JPY
-1,260,972,000 JPY
1,477,773,000 JPY
-1,128,026,000 JPY
-561,055,000 JPY
Net cash provided by (used in) investing activities
-41,677,000 JPY
-70,433,000 JPY
-40,945,000 JPY
-58,314,000 JPY
-38,131,000 JPY
Net cash provided by (used in) financing activities
1,064,987,000 JPY
724,423,000 JPY
2,121,748,000 JPY
687,522,000 JPY
295,814,000 JPY
Cash and cash equivalents
3,817,834,000 JPY
4,299,142,000 JPY
4,915,056,000 JPY
1,355,254,000 JPY
1,856,218,000 JPY
Number of employees
32 xbrli:pure
22 xbrli:pure
61 xbrli:pure
64 xbrli:pure
7 xbrli:pure
7 xbrli:pure
24 xbrli:pure
33 xbrli:pure
61 xbrli:pure
64 xbrli:pure
63 xbrli:pure
60 xbrli:pure
58 xbrli:pure
62 xbrli:pure
61 xbrli:pure
56 xbrli:pure
Average number of temporary employees
3 xbrli:pure
5 xbrli:pure
9 xbrli:pure
9 xbrli:pure
1 xbrli:pure
1 xbrli:pure
5 xbrli:pure
3 xbrli:pure
4 xbrli:pure
4 xbrli:pure
4 xbrli:pure
4 xbrli:pure
2 xbrli:pure
2 xbrli:pure
3 xbrli:pure
3 xbrli:pure
Total shareholder return
0.5186 xbrli:pure
0.5704 xbrli:pure
0.9991 xbrli:pure
0.4235 xbrli:pure
0.5308 xbrli:pure
Total return on share price index
1.4688 xbrli:pure
1.3028 xbrli:pure
1.2131 xbrli:pure
1.0270 xbrli:pure
1.2223 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.